Matrisome and Immune Pathways Contribute to Extreme Vascular Outcomes in Williams–Beuren Syndrome
Journal of the American Heart Association · 2024
DOI: 10.1161/jaha.123.031377 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Heart Association, 2024. Verfasst von Delong Liu und 24 weiteren Autor:innen. Beteiligte Einrichtung: National Heart, Lung, and Blood Institute National Institutes of Health Bethesda MD. Hauptthemen laut MEDLINE: Williams Syndrome, Aortic Stenosis, Supravalvular. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS.
Abstract (Originalsprache)
Background
Supravalvar aortic stenosis (SVAS) is a characteristic feature of Williams–Beuren syndrome (WBS). Its severity varies: ~20% of people with Williams–Beuren syndrome have SVAS requiring surgical intervention, whereas ~35% have no appreciable SVAS. The remaining individuals have SVAS of intermediate severity. Little is known about genetic modifiers that contribute to this variability. Methods and Results We performed genome sequencing on 473 individuals with Williams–Beuren syndrome and developed strategies for modifier discovery in this rare disease population. Approaches include extreme phenotyping and nonsynonymous variant prioritization, followed by gene set enrichment and pathway‐level association tests. We next used GTEx v8 and proteomic data sets to verify expression of candidate modifiers in relevant tissues. Finally, we evaluated overlap between the genes/pathways identified here and those ascertained through larger aortic disease/trait genome‐wide association studies. We show that SVAS severity in Williams–Beuren syndrome is associated with increased frequency of common and rarer variants in matrisome and immune pathways. Two implicated matrisome genes ( ACAN and LTBP4 ) were uniquely expressed in the aorta. Many genes in the identified pathways were previously reported in genome‐wide association studies for aneurysm, bicuspid aortic valve, or aortic size.
Conclusions
Smaller sample sizes in rare disease studies necessitate new approaches to detect modifiers. Our strategies identified variation in matrisome and immune pathways that are associated with SVAS severity. These findings suggest that, like other aortopathies, SVAS may be influenced by the balance of synthesis and degradation of matrisome proteins. Leveraging multiomic data and results from larger aorta‐focused genome‐wide association studies may accelerate modifier discovery for rare aortopathies like SVAS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- National Heart, Lung, and Blood Institute National Institutes of Health Bethesda MD.
- Department of Pediatrics University of Minnesota Minneapolis MN.
- The High Performance Computing Facility Center for Information Technology, National Institutes of Health Bethesda MD.
- Henry M Jackson Foundation for the Advancement of Military Medicine Bethesda MD.
- Department of Pediatrics University of Turin Italy.
- Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico Medical Genetic Unit Milan Italy.
ORCID-Profile: Delong Liu, Charles J Billington, Zoe C Wong, Mark D Levin, Wulfgang Resch, Camille Alba, Daniel N Hupalo, Maria Francesca Bedeschi, Gabriella Maria Squeo, Pheobe C R Parrish, Clifton L Dalgard, Giuseppe Merla, Barbara R Pober, Carolyn B Mervis, Amy E Roberts, Colleen A Morris, Lucy R Osborne, Beth A Kozel
Förderung
- NINDS NIH HHS
Zitieren
APA
Liu, D., Billington, C. J., Raja, N., Wong, Z. C., Levin, M. D., Resch, W., Alba, C., Hupalo, D. N., Biamino, E., Bedeschi, M. F., Digilio, M. C., Squeo, G. M., Villa, R., Parrish, P. C. R., Knutsen, R. H., Osgood, S., Freeman, J. A., Dalgard, C. L., Merla, G., …, & Kozel, B. A. (2024). Matrisome and Immune Pathways Contribute to Extreme Vascular Outcomes in Williams–Beuren Syndrome. Journal of the American Heart Association. https://doi.org/10.1161/jaha.123.031377
Vancouver
Liu D, Billington CJ, Raja N, Wong ZC, Levin MD, Resch W, et al. Matrisome and Immune Pathways Contribute to Extreme Vascular Outcomes in Williams–Beuren Syndrome. Journal of the American Heart Association. 2024. doi:10.1161/jaha.123.031377
BibTeX
@article{Liu2024,
author = {Liu, Delong and Billington, Charles J and Raja, Neelam and Wong, Zoe C and Levin, Mark D and Resch, Wulfgang and Alba, Camille and Hupalo, Daniel N and Biamino, Elisa and Bedeschi, Maria Francesca and Digilio, Maria Cristina and Squeo, Gabriella Maria and Villa, Roberta and Parrish, Pheobe C R and Knutsen, Russell H and Osgood, Sharon and Freeman, Joy A and Dalgard, Clifton L and Merla, Giuseppe and Pober, Barbara R and Mervis, Carolyn B and Roberts, Amy E and Morris, Colleen A and Osborne, Lucy R and Kozel, Beth A},
title = {Matrisome and Immune Pathways Contribute to Extreme Vascular Outcomes in Williams–Beuren Syndrome},
journal = {Journal of the American Heart Association},
year = {2024},
doi = {10.1161/jaha.123.031377}
}
EUVIMED